Connective tissue disease with macrophage activation syndrome: A case report

被引:0
作者
Chen, Qu [1 ]
Zhang, Qiushuang [1 ]
Wang, Xuebin [1 ]
机构
[1] Binzhou Med Univ Hosp, Dept Rheumatol, Binzhou, Shandong, Peoples R China
关键词
case report; hemophagocytic lymphocytosis; hemophagocytic syndrome; macrophage activation syndrome; tocilizumab; DIAGNOSIS; THERAPY;
D O I
10.1097/MD.0000000000032426
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rationale:Macrophage activation syndrome (MAS), or secondary hemophagocytic lymphocytosis (sHLH), is a rare systemic inflammatory response syndrome that is fatal. Adult patients lack clear criteria for diagnosis and treatment, primarily derived from guidelines and protocols for treating family hemophagocytic lymphocytosis and systemic juvenile idiopathic arthritis (sJIA)-related MAS in children or from retrospective case reports. As a subtype of sHLH, MAS has a clinical presentation like sHLH, but treatment varies. Herein, we report the case of a 40-year-old female with MAS caused by a connective tissue disease. Patient concerns:The patient presented to the Rheumatology and Immunology Clinic with recurrent fever and rash, and MAS was confirmed after a series of examinations. The patient had no significant effect after treatment with JAK inhibitors, but after the use of the IL-6 inhibitor tocilizumab, the fever and rash were significantly reduced, and laboratory indicators returned to normal levels. Diagnosis:Considering the patient's condition and laboratory test results, we judged that the patient had connective tissue disease with MAS. Interventions:We gave sequential treatment of tocilizumab. Outcomes:ALL indicators are mostly back to normal when the patient was monitored at the outpatient clinic. Lessons:MAS/HLH lacks clear criteria for diagnosis or treatment in adult patients and is extremely difficult to distinguish from bacterial sepsis or other systemic inflammatory response syndromes. Consequently, early diagnosis and treatment are indispensable for enhancing patient survival.
引用
收藏
页数:4
相关论文
共 14 条
[1]   Rapamycin as an Adjunctive Therapy for NLRC4 Associated Macrophage Activation Syndrome [J].
Barsalou, Julie ;
Blincoe, Annaliesse ;
Fernandez, Isabel ;
Dal-Soglio, Dorothee ;
Marchitto, Lorie ;
Selleri, Silvia ;
Haddad, Elie ;
Benyoucef, Aissa ;
Touzot, Fabien .
FRONTIERS IN IMMUNOLOGY, 2018, 9
[2]   Macrophage activation syndrome in adults: recent advances in pathophysiology, diagnosis and treatment [J].
Carter, Stuart J. ;
Tattersall, Rachel S. ;
Ramanan, Athimalaipet V. .
RHEUMATOLOGY, 2019, 58 (01) :5-17
[3]   The Immunology of Macrophage Activation Syndrome [J].
Crayne, Courtney B. ;
Albeituni, Sabrin ;
Nichols, Kim E. ;
Cron, Randy Q. .
FRONTIERS IN IMMUNOLOGY, 2019, 10
[4]   The rheumatoloay/hematology interface: CAPS and MAS diagnosis and management [J].
Gansner, John M. ;
Berliner, Nancy .
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2018, :313-317
[5]   Hemophagocytic lymphohistiocytosis: An update on pathogenesis, diagnosis, and therapy [J].
Griffin, Georgia ;
Shenoi, Susan ;
Hughes, Grant C. .
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2020, 34 (04)
[6]   Current status of the diagnosis and treatment of hemophagocytic lymphohistiocytosis in adults [J].
Kim, Yu Ri ;
Kim, Dae-Young .
BLOOD RESEARCH, 2021, 56 :17-25
[7]   Recommendations for the management of hemophagocytic lymphohistiocytosis in adults [J].
La Rosee, Paul ;
Horne, AnnaCarin ;
Hines, Melissa ;
Greenwood, Tatiana von Bahr ;
Machowicz, Rafal ;
Berliner, Nancy ;
Birndt, Sebastian ;
Gil-Herrera, Juana ;
Girschikofsky, Michael ;
Jordan, Michael B. ;
Kumar, Ashish ;
van Laar, Jan A. M. ;
Lachmann, Gunnar ;
Nichols, Kim E. ;
Ramanan, Athimalaipet, V ;
Wang, Yini ;
Wang, Zhao ;
Janka, Gritta ;
Henter, Jan-Inge .
BLOOD, 2019, 133 (23) :2465-2477
[8]   Salvage Therapy of Refractory Hemophagocytic Lymphohistiocytosis With Alemtuzumab [J].
Marsh, Rebecca A. ;
Allen, Carl E. ;
McClain, Kenneth L. ;
Weinstein, Joanna L. ;
Kanter, Julie ;
Skiles, Jodi ;
Lee, Nadine D. ;
Khan, Shakila P. ;
Lawrence, Julia ;
Mo, Jun Q. ;
Bleesing, Jack J. ;
Filipovich, Alexandra H. ;
Jordan, Michael B. .
PEDIATRIC BLOOD & CANCER, 2013, 60 (01) :101-109
[9]   Spontaneous Recovery of Hemophagocytic Lymphohistiocytosis Due to Primary Epstein-Barr Virus Infection in an Adult Patient [J].
Matsuo, Yuichiro ;
Iwanami, Keiichi ;
Hiraoka, Eiji ;
Oda, Rentaro .
AMERICAN JOURNAL OF CASE REPORTS, 2021, 22
[10]   Successful treatment of severe paediatric rheumatic disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive therapy: case series with 12 patients [J].
Miettunen, Paivi M. ;
Narendran, Aru ;
Jayanthan, Aarthi ;
Behrens, Edward M. ;
Cron, Randy Q. .
RHEUMATOLOGY, 2011, 50 (02) :417-419